← All trials
NCT03786081
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 27, 2019
- Primary completion
- Apr 30, 2021
- Completion date
- Apr 30, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 140
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- GenmabLead sponsor
- MerckCollaborator
- Seattle GeneticsCollaborator
- European Network for Gynaecological Oncological TrialCollaborator
- Katholieke Universiteit LeuvenCollaborator
- Gynecologic Oncology GroupCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.